# Lucian R. Chirieac

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lucian-r-chirieac/

## Facts

| Field | Value |
| --- | --- |
| Citations | 43,060 |
| Field | Occupational and environmental lung diseases |
| h-index | 80 |
| i10-index | 151 |
| Last Known Institution | Mount Sinai Hospital |
| OpenAlex ID | https://openalex.org/A5089159833 |
| ORCID iD | https://orcid.org/0000-0002-4383-6938 |
| Works | 356 |

## Researcher papers

Showing 12 of 13.

- [Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor <i>EML4-ALK</i>](https://scholariq.org/papers/clinical-features-and-outcome-of-patients-with-non-small-cell-lung-cancer-who/)
- [Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/non-small-cell-lung-cancer-version-3-2022-nccn-clinical-practice-guidelines-in/)
- [NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021](https://scholariq.org/papers/nccn-guidelines-insights-non-small-cell-lung-cancer-version-2-2021/)
- [NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020](https://scholariq.org/papers/nccn-guidelines-insights-non-small-cell-lung-cancer-version-1-2020/)
- [SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas](https://scholariq.org/papers/sox2-is-an-amplified-lineage-survival-oncogene-in-lung-and-esophageal-squamous/)
- [PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project](https://scholariq.org/papers/pd-l1-immunohistochemistry-comparability-study-in-real-life-clinical-samples/)
- [Non–Small Cell Lung Cancer, Version 4.2024](https://scholariq.org/papers/non-small-cell-lung-cancer-version-4-2024/)
- [NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 4.2016](https://scholariq.org/papers/nccn-guidelines-insights-non-small-cell-lung-cancer-version-4-2016/)
- [NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023](https://scholariq.org/papers/nccn-guidelines-insights-non-small-cell-lung-cancer-version-2-2023/)
- [Non–Small Cell Lung Cancer, Version 6.2015](https://scholariq.org/papers/non-small-cell-lung-cancer-version-6-2015/)
- [A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response](https://scholariq.org/papers/a-murine-lung-cancer-co-clinical-trial-identifies-genetic-modifiers-of/)
- [Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer](https://scholariq.org/papers/best-practices-recommendations-for-diagnostic-immunohistochemistry-in-lung/)

## Researcher topics

- [Occupational and environmental lung diseases](https://scholariq.org/topics/occupational-and-environmental-lung-diseases/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Medical Imaging and Pathology Studies](https://scholariq.org/topics/medical-imaging-and-pathology-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Pleural and Pulmonary Diseases](https://scholariq.org/topics/pleural-and-pulmonary-diseases/)

## Researcher university

- [Mount Sinai Hospital](https://scholariq.org/institutions/mount-sinai-hospital-3/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.